Bio-Rad Laboratories, Inc. (BIO-B) is a Healthcare company in the Medical Devices industry. It has a market capitalization of $9.01B, a trailing price-to-earnings ratio of 53.8 and a free-cash-flow yield of 4.1%. Over the most recent reported fiscal year, revenue grew 0.7% and free cash flow per share grew 45.5%.